BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24876164)

  • 1. A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources.
    Giehl KA; Kriz M; Grahovac M; Ruzicka T; Berking C
    Eur J Dermatol; 2014; 24(3):335-41. PubMed ID: 24876164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes.
    von Felbert V; Hoffmann G; Hoff-Lesch S; Abuzahra F; Renn CN; Braathen LR; Merk HF
    Br J Dermatol; 2010 Sep; 163(3):607-15. PubMed ID: 20426780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daylight photodynamic therapy: the Southern California experience.
    Lane KL; Hovenic W; Ball K; Zachary CB
    Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up.
    Sotiriou E; Apalla Z; Chovarda E; Goussi C; Trigoni A; Ioannides D
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):36-40. PubMed ID: 21366709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for facial actinic keratosis: a clinical and histological study in Chinese patients.
    Cai H; Wang YX; Sun P; Yang ZY; Tian R; Liu XY; Li Q; Qiao L; Liu W
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):260-5. PubMed ID: 23993852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-Modulated Photodynamic Therapy for the Treatment of Actinic Keratosis on the Extremities: A One-Year Follow-up Study.
    Willey A; Anderson RR; Sakamoto FH
    Dermatol Surg; 2015 Nov; 41(11):1290-5. PubMed ID: 26445287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-modulated photodynamic therapy for the treatment of actinic keratosis on the extremities: a pilot study.
    Willey A; Anderson RR; Sakamoto FH
    Dermatol Surg; 2014 Oct; 40(10):1094-102. PubMed ID: 25207759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with the use of superluminescent diodes (sLED) in the treatment of actinic keratosis.
    Bartosińska J; Wolska-Gawron K; Gerkowicz A; Niewiedzioł M; Michalska-Jakubus M; Komza M; Klepaczewski T; Kwaśny M; Krasowska D
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():187-190. PubMed ID: 29684690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, Controlled Trial of Fractional Carbon Dioxide Laser Resurfacing Followed by Ultrashort Incubation Aminolevulinic Acid Blue Light Photodynamic Therapy for Actinic Keratosis.
    Alexiades M
    Dermatol Surg; 2017 Aug; 43(8):1053-1064. PubMed ID: 28394858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
    Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
    Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
    Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
    Babilas P; Kohl E; Maisch T; Bäcker H; Gross B; Branzan AL; Bäumler W; Landthaler M; Karrer S; Szeimies RM
    Br J Dermatol; 2006 Apr; 154(4):712-8. PubMed ID: 16536815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
    Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
    Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis.
    Li L; Li Y; Dong H; Yan J; Zhang Y; Zhang C; Xu X
    Photodiagnosis Photodyn Ther; 2024 Jun; 47():104100. PubMed ID: 38663488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.